These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25870985)

  • 1. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
    Shah S; Ma Y; Scherzer R; Huhn G; French AL; Plankey M; Peters MG; Grunfeld C; Tien PC
    AIDS; 2015 Jul; 29(11):1325-33. PubMed ID: 25870985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
    Bailony MR; Scherzer R; Huhn G; Plankey MW; Peters MG; Tien PC
    J Infect Dis; 2013 Dec; 208(11):1776-83. PubMed ID: 23901097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlates of elevated interleukin-6 and C-reactive protein in persons with or at high risk for HCV and HIV infections.
    Salter ML; Lau B; Mehta SH; Go VF; Leng S; Kirk GD
    J Acquir Immune Defic Syndr; 2013 Dec; 64(5):488-95. PubMed ID: 23978997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
    Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
    Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-invasive assessment of liver steatosis and fibrosis in HIV/HCV- and HCV- infected patients.
    Li Vecchi V; Giannitrapani L; Di Carlo P; Mazzola G; Colletti P; La Spada E; Vizzini G; Montalto G; Soresi M
    Ann Hepatol; 2013; 12(5):740-8. PubMed ID: 24018492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
    J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced liver fibrosis by transient elastography, fibrosis 4, and alanine aminotransferase/platelet ratio index among Asian hepatitis C with and without human immunodeficiency virus infection: role of vitamin D levels.
    Avihingsanon A; Jitmitraparp S; Tangkijvanich P; Ramautarsing RA; Apornpong T; Jirajariyavej S; Putcharoen O; Treeprasertsuk S; Akkarathamrongsin S; Poovorawan Y; Matthews GV; Lange JM; Ruxrungtham K;
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1706-14. PubMed ID: 24730732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Markers of HIV Infection on Change in Liver Stiffness in People With HIV and Hepatitis C Virus Co-infection After Treatment and Cure of Hepatitis C.
    van Santen DK; Agius PA; Sasadeusz J; Fairley CK; Sievert W; Gane E; Iser D; O'Reilly M; Medland NA; Moore R; Hellard ME; Hoy JF; Doyle JS;
    J Acquir Immune Defic Syndr; 2020 Dec; 85(5):e81-e89. PubMed ID: 32842055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
    J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
    Kirk GD; Astemborski J; Mehta SH; Spoler C; Fisher C; Allen D; Higgins Y; Moore RD; Afdhal N; Torbenson M; Sulkowski M; Thomas DL
    Clin Infect Dis; 2009 Apr; 48(7):963-72. PubMed ID: 19236273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus drives increased type I interferon-associated impairments associated with fibrosis severity in antiretroviral treatment-treated HIV-1-hepatitis C virus-coinfected individuals.
    Griesbeck M; Valantin MA; Lacombe K; Samri-Hassimi A; Bottero J; Blanc C; Sbihi Z; Zoorob R; Katlama C; Guiguet M; Altfeld M; Autran B;
    AIDS; 2017 Jun; 31(9):1223-1234. PubMed ID: 28492391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation.
    Vispo E; Barreiro P; Del Valle J; Maida I; de Ledinghen V; Quereda C; Moreno A; Macías J; Castera L; Pineda JA; Soriano V
    Antivir Ther; 2009; 14(2):187-93. PubMed ID: 19430093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis progresses faster in HIV mono-infected than HIV/HCV co-infected patients and is associated with liver fibrosis.
    Pembroke T; Deschenes M; Lebouché B; Benmassaoud A; Sewitch M; Ghali P; Wong P; Halme A; Vuille-Lessard E; Pexos C; Klein MB; Sebastiani G
    J Hepatol; 2017 Oct; 67(4):801-808. PubMed ID: 28527666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
    Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
    Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of HIV infection and HIV/HCV coinfection with C-reactive protein levels: the fat redistribution and metabolic change in HIV infection (FRAM) study.
    Reingold J; Wanke C; Kotler D; Lewis C; Tracy R; Heymsfield S; Tien P; Bacchetti P; Scherzer R; Grunfeld C; Shlipak M
    J Acquir Immune Defic Syndr; 2008 Jun; 48(2):142-8. PubMed ID: 18344877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.